This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Harvard College, Vertex Pharmaceuticals, Inc.. Active years: 2004-2020.
Company Filing History:
Years Active: 2004-2020
Title: Innovations of Joshua Syken in Demyelinating Disease Treatment
Introduction
Joshua Syken is an accomplished inventor based in Jamaica Plain, MA (US), known for his significant contributions to the field of pharmaceuticals. He holds a total of four patents, focusing primarily on the treatment of demyelinating diseases.
Latest Patents
Among his latest patents, Syken has developed triazole compounds that are useful as modulators for demyelinating diseases. These compounds, along with their pharmaceutically acceptable salts, are designed to provide effective treatment options for various neurodegenerative conditions, including multiple sclerosis. His inventions also encompass methods of using these compositions and kits for therapeutic applications.
Career Highlights
Throughout his career, Joshua Syken has worked with notable organizations such as Vertex Pharmaceuticals, Inc. and Harvard College. His work in these institutions has allowed him to advance his research and contribute to the development of innovative treatments.
Collaborations
Some of his notable coworkers include Robert J Davies and Jingrong Cao, who have collaborated with him on various projects related to his inventions.
Conclusion
Joshua Syken's innovative work in the field of demyelinating disease treatment showcases his dedication to advancing medical science. His patents reflect a commitment to improving the lives of those affected by neurodegenerative diseases.